CN1636553A - 防挥发型固体制剂及其制造方法 - Google Patents

防挥发型固体制剂及其制造方法 Download PDF

Info

Publication number
CN1636553A
CN1636553A CNA2004100961166A CN200410096116A CN1636553A CN 1636553 A CN1636553 A CN 1636553A CN A2004100961166 A CNA2004100961166 A CN A2004100961166A CN 200410096116 A CN200410096116 A CN 200410096116A CN 1636553 A CN1636553 A CN 1636553A
Authority
CN
China
Prior art keywords
volatile
solid preparation
carboxymethyl cellulose
medicament
proof solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004100961166A
Other languages
English (en)
Chinese (zh)
Inventor
宫台信男
堀江敏彰
神户英芳
仓住敏明
村田悌治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN1636553A publication Critical patent/CN1636553A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2004100961166A 2003-11-28 2004-11-26 防挥发型固体制剂及其制造方法 Pending CN1636553A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003399851 2003-11-28
JP2003399851A JP5248733B2 (ja) 2003-11-28 2003-11-28 揮散防止型固形製剤およびその製造方法

Publications (1)

Publication Number Publication Date
CN1636553A true CN1636553A (zh) 2005-07-13

Family

ID=34724286

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004100961166A Pending CN1636553A (zh) 2003-11-28 2004-11-26 防挥发型固体制剂及其制造方法

Country Status (4)

Country Link
JP (1) JP5248733B2 (enExample)
KR (1) KR20050052361A (enExample)
CN (1) CN1636553A (enExample)
TW (1) TW200518774A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1965836B (zh) * 2005-11-09 2011-02-02 Ss制药株式会社 口服固体制剂及其制备方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5000491B2 (ja) * 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
JP2008127350A (ja) * 2006-11-22 2008-06-05 Ss Pharmaceut Co Ltd 臭いを防止した固形組成物
TWI392505B (zh) * 2006-11-22 2013-04-11 Ssp Co Ltd 固形組合物
WO2008072535A1 (ja) 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
CN101594863B (zh) * 2006-12-07 2011-12-07 第一三共株式会社 具有改进稳定性的涂膜制剂
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
KR102209574B1 (ko) * 2019-10-08 2021-02-01 주식회사 에스엔비아 싸이올 화합물 소취용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002266A1 (en) * 1987-09-17 1989-03-23 Mallinckrodt, Inc. A free-flowing granular composition containing ibuprofen and a method for its preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129138A (ja) * 1984-11-16 1986-06-17 Takeda Chem Ind Ltd 被覆製剤
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
JP2591235B2 (ja) * 1989-03-30 1997-03-19 吉富製薬株式会社 アルキルシステインまたはその酸付加塩を含有する安定な錠剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH0656677A (ja) * 1992-08-03 1994-03-01 Lion Corp 制酸剤組成物
JPH08310953A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形組成物
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002266A1 (en) * 1987-09-17 1989-03-23 Mallinckrodt, Inc. A free-flowing granular composition containing ibuprofen and a method for its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1965836B (zh) * 2005-11-09 2011-02-02 Ss制药株式会社 口服固体制剂及其制备方法

Also Published As

Publication number Publication date
JP5248733B2 (ja) 2013-07-31
TWI333421B (enExample) 2010-11-21
TW200518774A (en) 2005-06-16
JP2005162619A (ja) 2005-06-23
KR20050052361A (ko) 2005-06-02

Similar Documents

Publication Publication Date Title
JP5677391B2 (ja) 光安定性に優れた医薬製剤
TWI405574B (zh) 藥學固體製劑及其製造方法
TW200413006A (en) Solid dispersions comprising a hygroscopic and/or deliquescent drug
CN1189098A (zh) 用碱性试剂稳定的药物组合物
JP5854571B2 (ja) におい抑制方法
CN1794978A (zh) 未经制粒制备的包含阿伐他汀的药物组合物
JP6183979B2 (ja) アリピプラゾール無水物を含有する固形製剤の製造方法
CN1636553A (zh) 防挥发型固体制剂及其制造方法
CN121218983A (zh) 含有米洛巴林的医药组合物
JP2010189443A (ja) 揮散防止型固形製剤およびその製造方法
KR20080096779A (ko) 신규 필름 코팅정
CN1292743C (zh) 包衣的固体催眠制剂
JP5844574B2 (ja) ピタバスタチンを含有する安定化された薬物組成物
WO1997039752A1 (en) Sertindole preparation and process for the production thereof
JP6188091B2 (ja) メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤
WO2020111089A1 (ja) 医薬組成物
JP4874797B2 (ja) フィルムコーティング錠
JP2019034914A (ja) 良好な徐放性を有する、レボドパ含有小型化錠剤
US20070129329A1 (en) Stabilized pharmaceutical composition of pramipexole and method of preparation thereof
HK1076754A (en) Volatile proof solid preparation and producing method thereof
JP6461496B2 (ja) 解熱鎮痛製剤
WO2008152598A1 (en) Stabilized pharmaceutical compositions comprising atorvastatin
JP2007186444A (ja) プランルカスト含有製剤
JP2020111545A (ja) アジルサルタン含有組成物
MXPA06005846A (en) Method for the production of a solid, orally applicable pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1076754

Country of ref document: HK

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20050713

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1076754

Country of ref document: HK